Skip to main content
All lobbying filings

FEROX STRATEGIES

Lobbying for ATRIUM THERAPEUTICS · Biotechnology company

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 17, 2026
Income
$30,000.00
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Lobbyists on this filing 4
  • CRISTINA ANTELO New on this filing
    Previously held: Legal Fellow, Senate Democratic Steering Committee.
  • MARK WILLIAMS New on this filing
    Previously held: Chief of Staff, Rep. Michael Conaway // Chief of Staff, Rep. Todd Rokita // Dep. Chief of Staff/Leg. Director, Rep. Sam Johnson.
  • DEBRA DIXON New on this filing
    Previously held: Chief of staff to Rep. Xavier Becerra, legislative director to Rep. Becerra, legislative counsel to Rep. Becerra, chief of staff, Office of Policy and Planning, U.S. Department of Education, Immigration Counsel, U.S. Department of Justice
  • MICHAEL TAGGART New on this filing
    Previously held: Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 1
Health Issues

General issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem